Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for MNMD

Stock NameMind Medicine Inc
TickerMNMD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCA60255C8850

Show aggregate MNMD holdings

News associated with MNMD

Blair William & Co. IL Takes $73,000 Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Blair William & Co. IL acquired a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,500 shares of the company’s stock, valued at approximately $73,000. Several other large investors have also […] - 2025-08-14 05:02:58
MindMed Reports Strong Q2 2025 Results
Mind Medicine (MindMed)(NASDAQ:MNMD) reported Q2 2025 results on July 31, 2025. The company maintained strong enrollment momentum across all three pivotal phase 3 trials for MM120 ODT, confirmed a cash position of $237.9 million as of Q2 2025, sufficient to fund operations throug - 2025-08-11 05:37:30
1 Reason to Buy MindMed (MNMD)
Key PointsThe company must operate under strict regulations, as it is developing certain medicines based on psychedelic substances. - 2025-08-07 06:25:00
Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer
Oppenheimer assumed coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage issued an outperform rating and a $25.00 price objective on the stock. Other research analysts have also recently issued reports about the stock. Chardan Capital reissued a “buy” rating and set a […] - 2025-08-07 03:06:55
Mind Medicine (MindMed) (NASDAQ:MNMD) Given “Buy” Rating at Chardan Capital
Chardan Capital reissued their buy rating on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a research note released on Friday morning,Benzinga reports. Chardan Capital currently has a $20.00 price objective on the stock. Separately, Cantor Fitzgerald raised Mind Medicine (MindMed) to a “strong-buy” rating in a report on Tuesday, May 13th. Seven […] - 2025-08-04 02:48:46
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of “Buy” from Analysts
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have been given an average recommendation of “Buy” by the nine ratings firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The […] - 2025-07-29 02:14:49
Teacher Retirement System of Texas Sells 3,345 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Teacher Retirement System of Texas decreased its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 18.4% during the first quarter, HoldingsChannel reports. The firm owned 14,860 shares of the company’s stock after selling 3,345 shares during the quarter. Teacher Retirement System of Texas’ holdings in Mind Medicine (MindMed) were worth […] - 2025-07-22 04:12:51
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Target Price at $25.50
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the eleven analysts that are presently covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 1-year price […] - 2025-07-07 02:32:46
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of “Buy” from Brokerages
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned an average rating of “Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average 12-month […] - 2025-06-09 02:34:47
Reviewing Mind Medicine (MindMed) (NASDAQ:MNMD) and PacificHealth Laboratories (OTCMKTS:PHLI)
Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) and PacificHealth Laboratories (OTCMKTS:PHLI – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Analyst Recommendations This is a breakdown of […] - 2025-06-06 02:55:01
BNP Paribas Financial Markets Invests $74,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
BNP Paribas Financial Markets purchased a new position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the 4th quarter, Holdings Channel reports. The fund purchased 10,631 shares of the company’s stock, valued at approximately $74,000. Several other institutional investors have also modified their holdings of the company. Ameriprise Financial Inc. bought […] - 2025-06-02 04:44:55
Northern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Northern Trust Corp raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 12.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 684,836 shares of the company’s stock after purchasing an additional 76,559 shares during the period. […] - 2025-05-22 04:20:53
Raymond James Financial Inc. Acquires Shares of 16,004 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Raymond James Financial Inc. bought a new position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 16,004 shares of the company’s stock, valued at approximately $111,000. Several other institutional investors and hedge funds also recently bought and sold […] - 2025-05-14 04:22:48
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Bought by Wells Fargo & Company MN
Wells Fargo & Company MN raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 61.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 39,974 shares of the company’s stock after purchasing an additional 15,269 shares during the period. Wells Fargo & Company MN’s […] - 2025-05-07 04:18:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Legal & General Group Plc
Legal & General Group Plc cut its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 8.8% during the fourth quarter, HoldingsChannel reports. The fund owned 58,437 shares of the company’s stock after selling 5,639 shares during the period. Legal & General Group Plc’s holdings in Mind Medicine (MindMed) were worth $407,000 at […] - 2025-04-30 04:54:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $25.11 Consensus Target Price from Brokerages
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been given an average rating of “Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 12-month […] - 2025-04-23 02:30:49
Bank of New York Mellon Corp Boosts Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Bank of New York Mellon Corp boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 200,121 shares of the company’s stock after buying an additional 10,338 shares during the quarter. […] - 2025-03-24 05:08:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus Price Target from Brokerages
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has received a consensus rating of “Buy” from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-04 04:22:57
Warren Buffett's State of the Market
In this podcast, Motley Fool analyst Tim Beyers and host Dylan Lewis discuss: - 2025-03-03 14:29:00
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have received a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average […] - 2025-02-07 04:32:50
China Universal Asset Management Co. Ltd. Buys Shares of 15,549 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
China Universal Asset Management Co. Ltd. bought a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 15,549 shares of the company’s stock, valued at approximately $108,000. A number of other hedge funds have also made changes to their positions in […] - 2025-02-04 07:46:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) MNMD holdings

DateNumber of MNMD Shares HeldBase Market Value of MNMD SharesLocal Market Value of MNMD SharesChange in MNMD Shares HeldChange in MNMD Base ValueCurrent Price per MNMD Share HeldPrevious Price per MNMD Share Held
2025-11-12 (Wednesday)49,907MNMD holding increased by 129USD 605,871MNMD holding decreased by -15358USD 605,871129USD -15,358 USD 12.14 USD 12.48
2025-11-11 (Tuesday)49,778USD 621,229MNMD holding increased by 36337USD 621,2290USD 36,337 USD 12.48 USD 11.75
2025-11-10 (Monday)49,778MNMD holding increased by 128USD 584,892MNMD holding increased by 3987USD 584,892128USD 3,987 USD 11.75 USD 11.7
2025-11-07 (Friday)49,650USD 580,905MNMD holding increased by 17874USD 580,9050USD 17,874 USD 11.7 USD 11.34
2025-11-06 (Thursday)49,650MNMD holding increased by 128USD 563,031MNMD holding decreased by -7958USD 563,031128USD -7,958 USD 11.34 USD 11.53
2025-11-05 (Wednesday)49,522USD 570,989MNMD holding decreased by -23275USD 570,9890USD -23,275 USD 11.53 USD 12
2025-11-04 (Tuesday)49,522MNMD holding increased by 129USD 594,264MNMD holding decreased by -12776USD 594,264129USD -12,776 USD 12 USD 12.29
2025-11-03 (Monday)49,393USD 607,040MNMD holding decreased by -94341USD 607,0400USD -94,341 USD 12.29 USD 14.2
2025-10-31 (Friday)49,393USD 701,381MNMD holding increased by 40009USD 701,3810USD 40,009 USD 14.2 USD 13.39
2025-10-30 (Thursday)49,393MNMD holding increased by 645USD 661,372MNMD holding increased by 32035USD 661,372645USD 32,035 USD 13.39 USD 12.91
2025-10-29 (Wednesday)48,748MNMD holding increased by 258USD 629,337MNMD holding increased by 5271USD 629,337258USD 5,271 USD 12.91 USD 12.87
2025-10-28 (Tuesday)48,490USD 624,066MNMD holding increased by 1939USD 624,0660USD 1,939 USD 12.87 USD 12.83
2025-10-27 (Monday)48,490USD 622,127MNMD holding increased by 21821USD 622,1270USD 21,821 USD 12.83 USD 12.38
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MNMD by Blackrock for IE00BYXG2H39

Show aggregate share trades of MNMD

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12BUY12913.14012.110 12.213USD 1,575 8.18
2025-11-10BUY12812.89011.665 11.788USD 1,509 8.13
2025-11-06BUY12811.70011.130 11.187USD 1,432 8.09
2025-11-04BUY12912.53011.880 11.945USD 1,541 8.04
2025-10-30BUY64513.50012.600 12.690USD 8,185 7.94
2025-10-29BUY25812.91013.740 13.657USD 3,524 7.91
2025-10-22SELL-51212.43012.630 12.610USD -6,456 7.75 Loss of -2,486 on sale
2025-10-20BUY25613.16014.300 14.186USD 3,632 7.68
2025-10-17BUY63913.65013.860 13.839USD 8,843 7.64
2025-10-15BUY1,01612.66013.055 13.016USD 13,224 7.61
2025-10-03BUY90312.56012.760 12.740USD 11,504 7.54
2025-10-02BUY12912.22012.452 12.429USD 1,603 7.51
2025-09-30BUY25811.79012.000 11.979USD 3,091 7.44
2025-09-26BUY25810.67010.760 10.751USD 2,774 7.39
2025-09-25BUY2589.77010.300 10.247USD 2,644 7.37
2025-09-24BUY19.82010.190 10.153USD 10 7.35
2025-09-18BUY1319.4809.810 9.777USD 1,281 7.34
2025-09-17BUY3939.57010.040 9.993USD 3,927 7.32
2025-08-20SELL-5169.4509.560 9.549USD -4,927 7.25 Loss of -1,184 on sale
2025-07-30BUY5129.0309.440 9.399USD 4,812 7.14
2025-07-17SELL-2588.8808.880 8.880USD -2,291 6.96 Loss of -495 on sale
2025-07-11SELL-1,0408.0608.170 8.159USD -8,485 6.91 Loss of -1,296 on sale
2025-07-07BUY3907.2007.385 7.367USD 2,873 6.89
2025-07-02BUY7,1507.0807.200 7.188USD 51,394 6.88
2025-06-11BUY2627.4008.050 7.985USD 2,092 6.86
2025-06-10BUY2627.8908.195 8.164USD 2,139 6.85
2025-06-04SELL-1317.6507.920 7.893USD -1,034 6.82 Loss of -141 on sale
2025-04-23BUY1316.1106.330 6.308USD 826 6.84
2025-04-10SELL-1,0405.1405.511 5.474USD -5,693 7.05 Profit of 1,636 on sale
2025-04-08SELL-1304.8905.750 5.664USD -736 7.11 Profit of 189 on sale
2025-04-07SELL-1315.4305.550 5.538USD -725 7.15 Profit of 211 on sale
2025-04-04SELL-6605.4305.550 5.538USD -3,655 7.18 Profit of 1,085 on sale
2025-04-01BUY5325.5405.835 5.806USD 3,089 7.24
2025-03-31SELL-3965.8506.065 6.044USD -2,393 7.27 Profit of 486 on sale
2025-03-21BUY3,8006.7206.825 6.814USD 25,895 7.37
2025-03-14SELL-1,9206.3506.650 6.620USD -12,710 7.49 Profit of 1,663 on sale
2025-03-07SELL-2406.8306.910 6.902USD -1,656 7.65 Profit of 180 on sale
2025-03-04SELL-1206.2306.265 6.261USD -751 7.79 Profit of 183 on sale
2025-02-25BUY2406.7507.140 7.101USD 1,704 8.04
2025-02-19SELL-1188.2808.600 8.568USD -1,011 8.09 Loss of -56 on sale
2025-02-13BUY3548.6509.180 9.127USD 3,231 7.79
2025-02-12BUY1188.5108.671 8.655USD 1,021 7.73
2025-02-11BUY4728.2358.490 8.464USD 3,995 7.70
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MNMD

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19171,9770548,60131.3%
2025-09-18126,48340486,34026.0%
2025-09-17138,6901,410577,58624.0%
2025-09-16170,0470470,27936.2%
2025-09-15120,4140343,27335.1%
2025-09-12174,826500476,12836.7%
2025-09-11140,155772292,77947.9%
2025-09-10160,3837,052504,89331.8%
2025-09-09143,76619349,63541.1%
2025-09-08138,31842402,04734.4%
2025-09-05134,6018,324506,11226.6%
2025-09-04164,4740500,47132.9%
2025-09-03103,599481310,67033.3%
2025-09-02131,82633,495453,06829.1%
2025-08-29345,36751,132968,65935.7%
2025-08-28267,2715,682826,61332.3%
2025-08-2783,4301,100324,40325.7%
2025-08-2681,446939409,51319.9%
2025-08-25284,8885,3251,326,25721.5%
2025-08-22105,061675716,83114.7%
2025-08-2184,96010358,23923.7%
2025-08-20113,335877343,17933.0%
2025-08-1970,993985270,94626.2%
2025-08-18124,552410448,22027.8%
2025-08-1598,9591,329301,29232.8%
2025-08-14117,1612,144408,79028.7%
2025-08-13231,9823,631500,30446.4%
2025-08-12171,6162,072823,12320.8%
2025-08-11196,9381,675627,06031.4%
2025-08-08184,676325550,18733.6%
2025-08-07152,82260382,20340.0%
2025-08-06143,7111,477342,46542.0%
2025-08-05191,818446555,36434.5%
2025-08-04182,42735,147570,38432.0%
2025-08-01262,34927,304675,78638.8%
2025-07-31194,217456523,83737.1%
2025-07-30128,0628,953329,45838.9%
2025-07-29353,5081,661950,20737.2%
2025-07-28156,156120342,66145.6%
2025-07-25113,2772,780611,92418.5%
2025-07-24129,8302,868511,43725.4%
2025-07-23121,6211,561435,69327.9%
2025-07-22171,6932,099575,62629.8%
2025-07-21588,1577,6371,659,75235.4%
2025-07-18235,5893,310586,92140.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.